In line with what we have seen in non-tumor-bearing mice, the population of CD45+ cells was relatively lower in tumor-bearing mice with miR-17 overexpression (40.90% vs. 66.43%, p=0.04) (Figure 2a). Here, PTPRC is linked to neoplasm.